Skip to main content
NCBI home page
Clinical Microbiology Reviews logoLink to Clinical Microbiology Reviews
. 1991 Jan;4(1):1–19. doi: 10.1128/cmr.4.1.1

Candida mannan: chemistry, suppression of cell-mediated immunity, and possible mechanisms of action.

R D Nelson 1, N Shibata 1, R P Podzorski 1, M J Herron 1
PMCID: PMC358175  PMID: 2004345

Abstract

The ability of Candida albicans to establish an infection involves multiple components of this fungal pathogen, but its ability to persist in host tissue may involve primarily the immunosuppressive property of a major cell wall glycoprotein, mannan. Mannan and oligosaccharide fragments of mannan are potent inhibitors of cell-mediated immunity and appear to reproduce the immune deficit of patients with the mucocutaneous form of candidiasis. However, neither the exact structures of these inhibitory species nor their mechanisms of action have yet been clearly defined. Different investigators have proposed that mannan or mannan catabolites act upon monocytes or suppressor T lymphocytes, but research from unrelated areas has provided still other possibilities for consideration. These include interference with cytokine activities, lymphocyte-monocyte interactions, and leukocyte homing. To stimulate further research of the immunosuppressive property of C. albicans mannan, we have reviewed (i) the relationship of mannan to other antigens and virulence factors of the fungus; (ii) the chemistry of mannan, together with methods for preparation of mannan and mannan fragments; and (iii) the historical evidence for immunosuppression by Candida mannan and the mechanisms currently proposed for this property; and (iv) we have speculated upon still other mechanisms by which mannan might influence host defense functions. It is possible that understanding the immunosuppressive effects of mannan will provide clues to novel therapies for candidiasis that will enhance the efficacy of both available and future anti-Candida agents.

Full text

PDF
1

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ashwell J. D. Are B lymphocytes the principal antigen-presenting cells in vivo? J Immunol. 1988 Jun 1;140(11):3697–3700. [PubMed] [Google Scholar]
  2. Ausiello C. M., Spagnoli G. C., Boccanera M., Casalinuovo I., Malavasi F., Casciani C. U., Cassone A. Proliferation of human peripheral blood mononuclear cells induced by Candida albicans and its cell wall fractions. J Med Microbiol. 1986 Nov;22(3):195–202. doi: 10.1099/00222615-22-3-195. [DOI] [PubMed] [Google Scholar]
  3. Ballou C. Structure and biosynthesis of the mannan component of the yeast cell envelope. Adv Microb Physiol. 1976;14(11):93–158. doi: 10.1016/s0065-2911(08)60227-1. [DOI] [PubMed] [Google Scholar]
  4. Bankhurst A. D., Hastain E., Goodwin J. S., Peake G. T. The nature of the prostaglandin-producing mononuclear cell in human peripheral blood. J Lab Clin Med. 1981 Feb;97(2):179–186. [PubMed] [Google Scholar]
  5. Barrett-Bee K., Hayes Y., Wilson R. G., Ryley J. F. A comparison of phospholipase activity, cellular adherence and pathogenicity of yeasts. J Gen Microbiol. 1985 May;131(5):1217–1221. doi: 10.1099/00221287-131-5-1217. [DOI] [PubMed] [Google Scholar]
  6. Borg M., Rüchel R. Expression of extracellular acid proteinase by proteolytic Candida spp. during experimental infection of oral mucosa. Infect Immun. 1988 Mar;56(3):626–631. doi: 10.1128/iai.56.3.626-631.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bouchara J. P., Tronchin G., Annaix V., Robert R., Senet J. M. Laminin receptors on Candida albicans germ tubes. Infect Immun. 1990 Jan;58(1):48–54. doi: 10.1128/iai.58.1.48-54.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Brawner D. L., Cutler J. E. Ultrastructural and biochemical studies of two dynamically expressed cell surface determinants on Candida albicans. Infect Immun. 1986 Jan;51(1):327–336. doi: 10.1128/iai.51.1.327-336.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Brawner D. L., Cutler J. E. Variability in expression of a cell surface determinant on Candida albicans as evidenced by an agglutinating monoclonal antibody. Infect Immun. 1984 Mar;43(3):966–972. doi: 10.1128/iai.43.3.966-972.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Brown K. M., Muchmore A. V., Rosenstreich D. L. Uromodulin, an immunosuppressive protein derived from pregnancy urine, is an inhibitor of interleukin 1. Proc Natl Acad Sci U S A. 1986 Dec;83(23):9119–9123. doi: 10.1073/pnas.83.23.9119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Brown M. H., Cantrell D. A., Brattsand G., Crumpton M. J., Gullberg M. The CD2 antigen associates with the T-cell antigen receptor CD3 antigen complex on the surface of human T lymphocytes. Nature. 1989 Jun 15;339(6225):551–553. doi: 10.1038/339551a0. [DOI] [PubMed] [Google Scholar]
  12. Buckley R. H., Lucas Z. J., Hattler B. G., Jr, Zmijewski C. M., Amos D. B. Defective cellular immunity associated with chronic mucocutaneous moniliasis and recurrent staphylococcal botryomycosis: immunological reconstitution by allogeneic bone marrow. Clin Exp Immunol. 1968 Feb;3(2):153–169. [PMC free article] [PubMed] [Google Scholar]
  13. Canales L., Middlemas R. O., 3rd, Louro J. M., South M. A. Immunological observations in chronic mucocutaneous candidiasis. Lancet. 1969 Sep 13;2(7620):567–571. doi: 10.1016/s0140-6736(69)90264-5. [DOI] [PubMed] [Google Scholar]
  14. Cassone A., Kerridge D., Gale E. F. Ultrastructural changes in the cell wall of Candida albicans following cessation of growth and their possible relationship to the development of polyene resistance. J Gen Microbiol. 1979 Feb;110(2):339–349. doi: 10.1099/00221287-110-2-339. [DOI] [PubMed] [Google Scholar]
  15. Cassone A., Marconi P., Bistoni F. Cell wall of Candida albicans and host response. Crit Rev Microbiol. 1987;15(1):87–95. doi: 10.3109/10408418709104451. [DOI] [PubMed] [Google Scholar]
  16. Cassone A., Mattia E., Boldrini L. Agglutination of blastospores of Candida albicans by concanavalin A and its relationship with the distribution of mannan polymers and the ultrastructure of the cell wall. J Gen Microbiol. 1978 Apr;105(2):263–273. doi: 10.1099/00221287-105-2-263. [DOI] [PubMed] [Google Scholar]
  17. Catanzaro A. Suppressor cells in coccidioidomycosis. Cell Immunol. 1981 Nov 1;64(2):235–245. doi: 10.1016/0008-8749(81)90476-7. [DOI] [PubMed] [Google Scholar]
  18. Chattaway F. W., Holmes M. R., Barlow A. J. Cell wall composition of the mycelial and blastospore forms of Candida albicans. J Gen Microbiol. 1968 May;51(3):367–376. doi: 10.1099/00221287-51-3-367. [DOI] [PubMed] [Google Scholar]
  19. Chilgren R. A., Meuwissen H. J., Quie P. G., Good R. A., Hong R. The cellular immune defect in chronic mucocutaneous candidiasis. Lancet. 1969 Jun 28;1(7609):1286–1288. doi: 10.1016/s0140-6736(69)92223-5. [DOI] [PubMed] [Google Scholar]
  20. Chouaib S., Chatenoud L., Klatzmann D., Fradelizi D. The mechanisms of inhibition of human IL 2 production. II. PGE2 induction of suppressor T lymphocytes. J Immunol. 1984 Apr;132(4):1851–1857. [PubMed] [Google Scholar]
  21. Cillari E., Liew F. Y., Lelchuk R. Suppression of interleukin-2 production by macrophages in genetically susceptible mice infected with Leishmania major. Infect Immun. 1986 Nov;54(2):386–394. doi: 10.1128/iai.54.2.386-394.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Critchley I. A., Douglas L. J. Isolation and partial characterization of an adhesin from Candida albicans. J Gen Microbiol. 1987 Mar;133(3):629–636. doi: 10.1099/00221287-133-3-629. [DOI] [PubMed] [Google Scholar]
  23. Critchley I. A., Douglas L. J. Role of glycosides as epithelial cell receptors for Candida albicans. J Gen Microbiol. 1987 Mar;133(3):637–643. doi: 10.1099/00221287-133-3-637. [DOI] [PubMed] [Google Scholar]
  24. Cutler J. E., Friedman L., Milner K. C. Biological and chemical characterization of toxic substances from Candida albicans. Infect Immun. 1972 Oct;6(4):616–627. doi: 10.1128/iai.6.4.616-627.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. David J. R. Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc Natl Acad Sci U S A. 1966 Jul;56(1):72–77. doi: 10.1073/pnas.56.1.72. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Dinarello C. A., Marnoy S. O., Rosenwasser L. J. Role of arachidonate metabolism in the immunoregulatory function of human leukocytic pyrogen/lymphocyte-activating factor/interleukin 1. J Immunol. 1983 Feb;130(2):890–895. [PubMed] [Google Scholar]
  27. Dinarello C. A., Mier J. W. Lymphokines. N Engl J Med. 1987 Oct 8;317(15):940–945. doi: 10.1056/NEJM198710083171506. [DOI] [PubMed] [Google Scholar]
  28. Djeu J. Y., Blanchard D. K., Halkias D., Friedman H. Growth inhibition of Candida albicans by human polymorphonuclear neutrophils: activation by interferon-gamma and tumor necrosis factor. J Immunol. 1986 Nov 1;137(9):2980–2984. [PubMed] [Google Scholar]
  29. Domer J. E. Candida cell wall mannan: a polysaccharide with diverse immunologic properties. Crit Rev Microbiol. 1989;17(1):33–51. doi: 10.3109/10408418909105721. [DOI] [PubMed] [Google Scholar]
  30. Domer J. E., Garner R. E., Befidi-Mengue R. N. Mannan as an antigen in cell-mediated immunity (CMI) assays and as a modulator of mannan-specific CMI. Infect Immun. 1989 Mar;57(3):693–700. doi: 10.1128/iai.57.3.693-700.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Domer J. E., Stashak P. W., Elkins K., Prescott B., Caldes G., Baker P. J. Separation of immunomodulatory effects of mannan from Candida albicans into stimulatory and suppressive components. Cell Immunol. 1986 Sep;101(2):403–414. doi: 10.1016/0008-8749(86)90153-x. [DOI] [PubMed] [Google Scholar]
  32. Douglas L. J. Adhesion of Candida species to epithelial surfaces. Crit Rev Microbiol. 1987;15(1):27–43. doi: 10.3109/10408418709104446. [DOI] [PubMed] [Google Scholar]
  33. Douglas L. J. Adhesion of pathogenic Candida species to host surfaces. Microbiol Sci. 1985 Aug;2(8):243–247. [PubMed] [Google Scholar]
  34. Durandy A., Fischer A., Charron D. J., Griscelli C. Restriction of the in vitro anti-mannan antibody response by HLA-DQ molecules. Hum Immunol. 1986 May;16(1):114–125. doi: 10.1016/0198-8859(86)90040-6. [DOI] [PubMed] [Google Scholar]
  35. Durandy A., Fischer A., Charron D., Griscelli C. Specific binding of antigen onto human T lymphocytes. J Clin Invest. 1986 May;77(5):1557–1564. doi: 10.1172/JCI112471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Durandy A., Fischer A., Le Deist F., Drouhet E., Griscelli C. Mannan-specific and mannan-induced T-cell suppressive activity in patients with chronic mucocutaneous candidiasis. J Clin Immunol. 1987 Sep;7(5):400–409. doi: 10.1007/BF00917018. [DOI] [PubMed] [Google Scholar]
  37. Edwards C. K., 3rd, Hedegaard H. B., Zlotnik A., Gangadharam P. R., Johnston R. B., Jr, Pabst M. J. Chronic infection due to Mycobacterium intracellulare in mice: association with macrophage release of prostaglandin E2 and reversal by injection of indomethacin, muramyl dipeptide, or interferon-gamma. J Immunol. 1986 Mar 1;136(5):1820–1827. [PubMed] [Google Scholar]
  38. Edwards J. E., Jr, Gaither T. A., O'Shea J. J., Rotrosen D., Lawley T. J., Wright S. A., Frank M. M., Green I. Expression of specific binding sites on Candida with functional and antigenic characteristics of human complement receptors. J Immunol. 1986 Dec 1;137(11):3577–3583. [PubMed] [Google Scholar]
  39. Ellsworth J. H., Reiss E., Bradley R. L., Chmel H., Armstrong D. Comparative serological and cutaneous reactivity of candidal cytoplasmic proteins and mannan separated by affinity for concanavalin A. J Clin Microbiol. 1977 Jan;5(1):91–99. doi: 10.1128/jcm.5.1.91-99.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Elorza M. V., Marcilla A., Sentandreu R. Wall mannoproteins of the yeast and mycelial cells of Candida albicans: nature of the glycosidic bonds and polydispersity of their mannan moieties. J Gen Microbiol. 1988 Aug;134(8):2393–2403. doi: 10.1099/00221287-134-8-2393. [DOI] [PubMed] [Google Scholar]
  41. Elorza M. V., Rico H., Gozalbo D., Sentandreu R. Cell wall composition and protoplast regeneration in Candida albicans. Antonie Van Leeuwenhoek. 1983 Nov;49(4-5):457–469. doi: 10.1007/BF00399324. [DOI] [PubMed] [Google Scholar]
  42. Elorza M. V., Rico H., Sentandreu R. Calcofluor white alters the assembly of chitin fibrils in Saccharomyces cerevisiae and Candida albicans cells. J Gen Microbiol. 1983 May;129(5):1577–1582. doi: 10.1099/00221287-129-5-1577. [DOI] [PubMed] [Google Scholar]
  43. Ezekowitz R. A., Stahl P. D. The structure and function of vertebrate mannose lectin-like proteins. J Cell Sci Suppl. 1988;9:121–133. doi: 10.1242/jcs.1988.supplement_9.6. [DOI] [PubMed] [Google Scholar]
  44. Farrar W. L., Humes J. L. The role of arachidonic acid metabolism in the activities of interleukin 1 and 2. J Immunol. 1985 Aug;135(2):1153–1159. [PubMed] [Google Scholar]
  45. Fearon D. T., Wong W. W. Complement ligand-receptor interactions that mediate biological responses. Annu Rev Immunol. 1983;1:243–271. doi: 10.1146/annurev.iy.01.040183.001331. [DOI] [PubMed] [Google Scholar]
  46. Fischer A., Ballet J. J., Griscelli C. Specific inhibition of in vitro Candida-induced lymphocyte proliferation by polysaccharidic antigens present in the serum of patients with chronic mucocutaneous candidiasis. J Clin Invest. 1978 Nov;62(5):1005–1013. doi: 10.1172/JCI109204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Fischer A., Durandy A., Griscelli C. Role of prostaglandin E2 in the induction of nonspecific T lymphocyte suppressor activity. J Immunol. 1981 Apr;126(4):1452–1455. [PubMed] [Google Scholar]
  48. Fischer A., Pichat L., Audinot M., Griscelli C. Defective handling of mannan by monocytes in patients with chronic mucocutaneous candidiasis resulting in a specific cellular unresponsiveness. Clin Exp Immunol. 1982 Mar;47(3):653–660. [PMC free article] [PubMed] [Google Scholar]
  49. Funayama M., Nishikawa A., Shinoda T., Suzuki M., Fukazawa Y. Antigenic relationship between Candida parapsilosis and Candida albicans serotype B. Microbiol Immunol. 1984;28(12):1359–1371. doi: 10.1111/j.1348-0421.1984.tb00794.x. [DOI] [PubMed] [Google Scholar]
  50. Gatenby P., Basten A., Adams E. Thymoma and late onset mucocutaneous candidiasis associated with a plasma inhibitor of cell-mediated immune function. J Clin Lab Immunol. 1980 May;3(3):209–216. [PubMed] [Google Scholar]
  51. Gettner S. M., Mackenzie D. W. Responses of human peripheral lymphocytes to soluble and insoluble antigens of Candida albicans. J Med Microbiol. 1981 Aug;14(3):333–340. doi: 10.1099/00222615-14-3-333. [DOI] [PubMed] [Google Scholar]
  52. Gilmore B. J., Retsinas E. M., Lorenz J. S., Hostetter M. K. An iC3b receptor on Candida albicans: structure, function, and correlates for pathogenicity. J Infect Dis. 1988 Jan;157(1):38–46. doi: 10.1093/infdis/157.1.38. [DOI] [PubMed] [Google Scholar]
  53. Goldberg L. S., Bluestone R., Barnett E. V., Landau J. W. Studies on lymphocyte and monocyte function in chronic mucocutaneous candidiasis. Clin Exp Immunol. 1971 Jan;8(1):37–43. [PMC free article] [PubMed] [Google Scholar]
  54. Goodwin J. S., Ceuppens J. Regulation of the immune response by prostaglandins. J Clin Immunol. 1983 Oct;3(4):295–315. doi: 10.1007/BF00915791. [DOI] [PubMed] [Google Scholar]
  55. HASENCLEVER H. F., MITCHELL W. O. Antigenic studies of Candida. I. Observation of two antigenic groups in Candida albicans. J Bacteriol. 1961 Oct;82:570–573. doi: 10.1128/jb.82.4.570-573.1961. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Hase S., Ibuki T., Ikenaka T. Reexamination of the pyridylamination used for fluorescence labeling of oligosaccharides and its application to glycoproteins. J Biochem. 1984 Jan;95(1):197–203. doi: 10.1093/oxfordjournals.jbchem.a134585. [DOI] [PubMed] [Google Scholar]
  57. Heidenreich F., Dierich M. P. Candida albicans and Candida stellatoidea, in contrast to other Candida species, bind iC3b and C3d but not C3b. Infect Immun. 1985 Nov;50(2):598–600. doi: 10.1128/iai.50.2.598-600.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Hermans P. E., Ulrich J. A., Markowitz H. Chronic mucocutaneous candidiasis as a surface expression of deep-seated abnormalities. Report of a syndrome of superficial candidiasis, absence of delayed hypersensitivity and aminoaciduria. Am J Med. 1969 Oct;47(4):503–519. doi: 10.1016/0002-9343(69)90181-8. [DOI] [PubMed] [Google Scholar]
  59. Herriott M. J., Leu R. W. Activation of mouse macrophages for migration inhibition and for tumor cytotoxicity is mediated by interferon-gamma priming and triggering by various agents. J Interferon Res. 1987 Apr;7(2):165–171. doi: 10.1089/jir.1987.7.165. [DOI] [PubMed] [Google Scholar]
  60. Hession C., Decker J. M., Sherblom A. P., Kumar S., Yue C. C., Mattaliano R. J., Tizard R., Kawashima E., Schmeissner U., Heletky S. Uromodulin (Tamm-Horsfall glycoprotein): a renal ligand for lymphokines. Science. 1987 Sep 18;237(4821):1479–1484. doi: 10.1126/science.3498215. [DOI] [PubMed] [Google Scholar]
  61. Hoflack B., Kornfeld S. Lysosomal enzyme binding to mouse P388D1 macrophage membranes lacking the 215-kDa mannose 6-phosphate receptor: evidence for the existence of a second mannose 6-phosphate receptor. Proc Natl Acad Sci U S A. 1985 Jul;82(13):4428–4432. doi: 10.1073/pnas.82.13.4428. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Holt P. J., Higgs J. M., Munro J., Valdimarsson H. Chronic mucocutaneous candidiasis: a model for the investigation of cell mediated immunity. Br J Clin Pract. 1972 Jul;26(7):331–336. [PubMed] [Google Scholar]
  63. Hopwood V., Poulain D., Fortier B., Evans G., Vernes A. A monoclonal antibody to a cell wall component of Candida albicans. Infect Immun. 1986 Oct;54(1):222–227. doi: 10.1128/iai.54.1.222-227.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Jerrells T. R. Immunosuppression associated with the development of chronic infections with Rickettsia tsutsugamushi: adherent suppressor cell activity and macrophage activation. Infect Immun. 1985 Oct;50(1):175–182. doi: 10.1128/iai.50.1.175-182.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Jimenez-Finkel B. E., Murphy J. W. Induction of antigen-specific T suppressor cells by soluble Paracoccidioides brasiliensis antigen. Infect Immun. 1988 Apr;56(4):734–743. doi: 10.1128/iai.56.4.734-743.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Jones G. W., Isaacson R. E. Proteinaceous bacterial adhesins and their receptors. Crit Rev Microbiol. 1983;10(3):229–260. doi: 10.3109/10408418209113564. [DOI] [PubMed] [Google Scholar]
  67. Jorizzo J. L. Chronic mucocutaneous candidosis. An update. Arch Dermatol. 1982 Dec;118(12):963–965. [PubMed] [Google Scholar]
  68. KESSLER G., NICKERSON W. J. Glucomannan-protein complexes from cell walls of yeasts. J Biol Chem. 1959 Sep;234:2281–2285. [PubMed] [Google Scholar]
  69. KORN E. D., NORTHCOTE D. H. Physical and chemical properties of polysaccharides and glycoproteins of the yeast-cell wall. Biochem J. 1960 Apr;75:12–17. doi: 10.1042/bj0750012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Kennedy M. J., Rogers A. L., Hanselmen L. R., Soll D. R., Yancey R. J., Jr Variation in adhesion and cell surface hydrophobicity in Candida albicans white and opaque phenotypes. Mycopathologia. 1988 Jun;102(3):149–156. doi: 10.1007/BF00437397. [DOI] [PubMed] [Google Scholar]
  71. Kirkpatrick C. H., Chandler J. W., Schimke R. N. Chronic mucocutaneous moniliasis with impaired delayed hypersensitivity. Clin Exp Immunol. 1970 Mar;6(3):375–385. [PMC free article] [PubMed] [Google Scholar]
  72. Kirkpatrick C. H. Chronic mucocutaneous candidiasis. Eur J Clin Microbiol Infect Dis. 1989 May;8(5):448–456. doi: 10.1007/BF01964059. [DOI] [PubMed] [Google Scholar]
  73. Kirkpatrick C. H., Rich R. R., Bennett J. E. Chronic mucocutaneous candidiasis: model-building in cellular immunity. Ann Intern Med. 1971 Jun;74(6):955–978. doi: 10.7326/0003-4819-74-6-955. [DOI] [PubMed] [Google Scholar]
  74. Kirkpatrick C. H., Rich R. R., Graw R. G., Jr, Smith T. K., Mickenberg I., Rogentine G. N. Treatment of chronic mucocutaneous moniliasis by immunologic reconstitution. Clin Exp Immunol. 1971 Dec;9(6):733–748. [PMC free article] [PubMed] [Google Scholar]
  75. Kishimoto T. K., Jutila M. A., Butcher E. C. Identification of a human peripheral lymph node homing receptor: a rapidly down-regulated adhesion molecule. Proc Natl Acad Sci U S A. 1990 Mar;87(6):2244–2248. doi: 10.1073/pnas.87.6.2244. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Kobayashi H., Shibata N., Mitobe H., Ohkubo Y., Suzuki S. Structural study of phosphomannan of yeast-form cells of Candida albicans J-1012 strain with special reference to application of mild acetolysis. Arch Biochem Biophys. 1989 Aug 1;272(2):364–375. doi: 10.1016/0003-9861(89)90230-0. [DOI] [PubMed] [Google Scholar]
  77. Kobayashi H., Shibata N., Nakada M., Chaki S., Mizugami K., Ohkubo Y., Suzuki S. Structural study of cell wall phosphomannan of Candida albicans NIH B-792 (serotype B) strain, with special reference to 1H and 13C NMR analyses of acid-labile oligomannosyl residues. Arch Biochem Biophys. 1990 Apr;278(1):195–204. doi: 10.1016/0003-9861(90)90248-w. [DOI] [PubMed] [Google Scholar]
  78. Kobayashi H., Shibata N., Yonezu T., Suzuki S. Structural study of phosphomannan-protein complex of Citeromyces matritensis containing beta-1,2 linkage. Application of partial acid degradation and acetolysis techniques under mild conditions. Arch Biochem Biophys. 1987 Jul;256(1):381–396. doi: 10.1016/0003-9861(87)90459-0. [DOI] [PubMed] [Google Scholar]
  79. Kocourek J., Ballou C. E. Method for fingerprinting yeast cell wall mannans. J Bacteriol. 1969 Dec;100(3):1175–1181. doi: 10.1128/jb.100.3.1175-1181.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Kolotila M. P., Diamond R. D. Effects of neutrophils and in vitro oxidants on survival and phenotypic switching of Candida albicans WO-1. Infect Immun. 1990 May;58(5):1174–1179. doi: 10.1128/iai.58.5.1174-1179.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Koster F. T., Williams J. C., Goodwin J. S. Cellular immunity in Q fever: modulation of responsiveness by a suppressor T cell-monocyte circuit. J Immunol. 1985 Aug;135(2):1067–1072. [PubMed] [Google Scholar]
  82. Kwon-Chung K. J., Tom W. K. Unilateral involvement of kidneys in mice infected with Candida albicans. Sabouraudia. 1985 Feb;23(1):81–83. doi: 10.1080/00362178585380131. [DOI] [PubMed] [Google Scholar]
  83. LIACOPOULOS P., NEVEU T. NON-SPECIFIC INHIBITION OF THE IMMEDIATE AND DELAYED TYPES OF HYPERSENSITIVITY DURING IMMUNE PARALYSIS OF ADULT GUINEA-PIGS. Immunology. 1964 Jan;7:26–39. [PMC free article] [PubMed] [Google Scholar]
  84. Lawrence H. S. Transfer factor. Adv Immunol. 1969;11:195–266. doi: 10.1016/s0065-2776(08)60480-0. [DOI] [PubMed] [Google Scholar]
  85. Lehner T., Wilton J. M., Ivanyi L. Immunodeficiencies in chronic muco-cutaneous candidosis. Immunology. 1972 May;22(5):775–787. [PMC free article] [PubMed] [Google Scholar]
  86. Linehan L., Wadsworth E., Calderone R. Candida albicans C3d receptor, isolated by using a monoclonal antibody. Infect Immun. 1988 Aug;56(8):1981–1986. doi: 10.1128/iai.56.8.1981-1986.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Lloyd K. O. Isolation, characterization, and partial structure of peptido galactomannans from the yeast form of Cladosporium werneckii. Biochemistry. 1970 Aug 18;9(17):3446–3453. doi: 10.1021/bi00819a025. [DOI] [PubMed] [Google Scholar]
  88. Lyon F. L., Domer J. E. Chemical and enzymatic variation in the cell walls of pathogenic Candida species. Can J Microbiol. 1985 Jul;31(7):590–597. doi: 10.1139/m85-112. [DOI] [PubMed] [Google Scholar]
  89. Macdonald F., Odds F. C. Virulence for mice of a proteinase-secreting strain of Candida albicans and a proteinase-deficient mutant. J Gen Microbiol. 1983 Feb;129(2):431–438. doi: 10.1099/00221287-129-2-431. [DOI] [PubMed] [Google Scholar]
  90. Macdonald F. Secretion of inducible proteinase by pathogenic Candida species. Sabouraudia. 1984;22(1):79–82. [PubMed] [Google Scholar]
  91. Manning M., Mitchell T. G. Analysis of cytoplasmic antigens of the yeast and mycelial phases of Candida albicans by two-dimensional electrophoresis. Infect Immun. 1980 Nov;30(2):484–495. doi: 10.1128/iai.30.2.484-495.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Marmor M. F., Barnett E. V. Cutaneous anergy without systemic disease. A syndrome associated with mucocutaneous fungal infection. Am J Med. 1968 Jun;44(6):979–989. doi: 10.1016/0002-9343(68)90097-1. [DOI] [PubMed] [Google Scholar]
  93. McCourtie J., Douglas L. J. Relationship between cell surface composition of Candida albicans and adherence to acrylic after growth on different carbon sources. Infect Immun. 1981 Jun;32(3):1234–1241. doi: 10.1128/iai.32.3.1234-1241.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  94. McInnes A., Rennick D. M. Interleukin 4 induces cultured monocytes/macrophages to form giant multinucleated cells. J Exp Med. 1988 Feb 1;167(2):598–611. doi: 10.1084/jem.167.2.598. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Mehra V., Mason L. H., Fields J. P., Bloom B. R. Lepromin-induced suppressor cells in patients with leprosy. J Immunol. 1979 Oct;123(4):1813–1817. [PubMed] [Google Scholar]
  96. Metzger Z., Hoffeld J. T., Oppenheim J. J. Macrophage-mediated suppression. I. Evidence for participation of both hdyrogen peroxide and prostaglandins in suppression of murine lymphocyte proliferation. J Immunol. 1980 Feb;124(2):983–988. [PubMed] [Google Scholar]
  97. Mizuochi T., Yonemasu K., Yamashita K., Kobata A. The asparagine-linked sugar chains of subcomponent C1q of the first component of human complement. J Biol Chem. 1978 Oct 25;253(20):7404–7409. [PubMed] [Google Scholar]
  98. Montes L. F., Wilborn W. H. Fungus-host relationship in candidiasis. A brief review. Arch Dermatol. 1985 Jan;121(1):119–124. [PubMed] [Google Scholar]
  99. Muchmore A. V., Decker J. M., Blaese R. M. Evidence that specific oligosaccharides block early events necessary for the expression of antigen-specific proliferation by human lymphocytes. J Immunol. 1980 Sep;125(3):1306–1311. [PubMed] [Google Scholar]
  100. Muchmore A. V., Decker J. M., Blaese R. M., Nilsson B. Purification and characterization of a mannose-containing disaccharide obtained from human pregnancy urine. A new immunoregulatory saccharide. J Exp Med. 1984 Dec 1;160(6):1672–1685. doi: 10.1084/jem.160.6.1672. [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. Muchmore A. V., Decker J. M., Blaese R. M. Spontaneous cytotoxicity by human peripheral blood monocytes: inhibition by monosaccharides and oligosaccharides. Immunobiology. 1981;158(3):191–206. doi: 10.1016/S0171-2985(81)80069-1. [DOI] [PubMed] [Google Scholar]
  102. Muchmore A. V., Decker J. M. Uromodulin. An immunosuppressive 85-kilodalton glycoprotein isolated from human pregnancy urine is a high affinity ligand for recombinant interleukin 1 alpha. J Biol Chem. 1986 Oct 15;261(29):13404–13407. [PubMed] [Google Scholar]
  103. Muchmore A. V., Decker J. M. Uromodulin: a unique 85-kilodalton immunosuppressive glycoprotein isolated from urine of pregnant women. Science. 1985 Aug 2;229(4712):479–481. doi: 10.1126/science.2409603. [DOI] [PubMed] [Google Scholar]
  104. Murgui A., Elorza M. V., Sentandreu R. Tunicamycin and papulacandin B inhibit incorporation of specific mannoproteins into the wall of Candida albicans regenerating protoplasts. Biochim Biophys Acta. 1986 Dec 10;884(3):550–558. doi: 10.1016/0304-4165(86)90207-2. [DOI] [PubMed] [Google Scholar]
  105. Murphy J. W., Mosley R. L. Regulation of cell-mediated immunity in cryptococcosis. III. Characterization of second-order T suppressor cells (Ts2). J Immunol. 1985 Jan;134(1):577–584. [PubMed] [Google Scholar]
  106. NOWELL P. C. Phytohemagglutinin: an initiator of mitosis in cultures of normal human leukocytes. Cancer Res. 1960 May;20:462–466. [PubMed] [Google Scholar]
  107. Nakajima T., Ballou C. E. Characterization of the carbohydrate fragments obtained from Saccharomyces cerevisiae mannan by alkaline degradation. J Biol Chem. 1974 Dec 10;249(23):7679–7684. [PubMed] [Google Scholar]
  108. Nakajima T., Ballou C. E. Structure of the linkage region between the polysaccharide and protein parts of Saccharomyces cerevisiae mannan. J Biol Chem. 1974 Dec 10;249(23):7685–7694. [PubMed] [Google Scholar]
  109. Nelson R. D., Herron M. J., McCormack R. T., Gehrz R. C. Two mechanisms of inhibition of human lymphocyte proliferation by soluble yeast mannan polysaccharide. Infect Immun. 1984 Mar;43(3):1041–1046. doi: 10.1128/iai.43.3.1041-1046.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  110. Odds F. C. Morphogenesis in Candida albicans. Crit Rev Microbiol. 1985;12(1):45–93. doi: 10.3109/10408418509104425. [DOI] [PubMed] [Google Scholar]
  111. Okubo Y., Honma Y., Suzuki S. Relationship between phosphate content and serological activities of the mannans of Candida albicans strains NIH A-207, NIH B-792, and J-1012. J Bacteriol. 1979 Jan;137(1):677–680. doi: 10.1128/jb.137.1.677-680.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  112. Ollert M. W., Wadsworth E., Calderone R. A. Reduced expression of the functionally active complement receptor for iC3b but not for C3d on an avirulent mutant of Candida albicans. Infect Immun. 1990 Apr;58(4):909–913. doi: 10.1128/iai.58.4.909-913.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  113. Paterson P. Y., Semo R., Blumenschein G., Swelstad J. Mucocutaneous candidiasis, anergy and a plasma inhibitor of cellular immunity: reversal after amphotericin B therapy. Clin Exp Immunol. 1971 Nov;9(5):595–602. [PMC free article] [PubMed] [Google Scholar]
  114. Perfect J. R., Granger D. L., Durack D. T. Effects of antifungal agents and gamma interferon on macrophage cytotoxicity for fungi and tumor cells. J Infect Dis. 1987 Aug;156(2):316–323. doi: 10.1093/infdis/156.2.316. [DOI] [PubMed] [Google Scholar]
  115. Petit J. C., Richard G., Burghoffer B., Daguet G. L. Suppression of cellular immunity to Listeria monocytogenes by activated macrophages: mediation by prostaglandins. Infect Immun. 1985 Aug;49(2):383–388. doi: 10.1128/iai.49.2.383-388.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  116. Piccolella E., Lombardi G., Morelli R. Generation of suppressor cells in the response of human lymphocytes to a polysaccharide from Candida albicans. J Immunol. 1981 Jun;126(6):2151–2155. [PubMed] [Google Scholar]
  117. Piccolella E., Lombardi G., Morelli R. Human lymphocyte-activating properties of a purified polysaccharide from Candida albicans: B and T cell cooperation in the mitogenic response. J Immunol. 1980 Nov;125(5):2082–2088. [PubMed] [Google Scholar]
  118. Piessens W. F., Churchill W. H., Jr, David Macrophages activated in vitro with lymphocyte mediators kill neoplastic but not normal cells. J Immunol. 1975 Jan;114(1 Pt 2):293–299. [PubMed] [Google Scholar]
  119. Piessens W. F., Ratiwayanto S., Tuti S., Palmieri J. H., Piessens P. W., Koiman I., Dennis D. T. Antigen-specific suppressor cells and suppressor factors in human filariasis with Brugia malayi. N Engl J Med. 1980 Apr 10;302(15):833–837. doi: 10.1056/NEJM198004103021503. [DOI] [PubMed] [Google Scholar]
  120. Podzorski R. P., Gray G. R., Nelson R. D. Different effects of native Candida albicans mannan and mannan-derived oligosaccharides on antigen-stimulated lymphoproliferation in vitro. J Immunol. 1990 Jan 15;144(2):707–716. [PubMed] [Google Scholar]
  121. Podzorski R. P., Herron M. J., Fast D. J., Nelson R. D. Pathogenesis of candidiasis. Immunosuppression by cell wall mannan catabolites. Arch Surg. 1989 Nov;124(11):1290–1294. doi: 10.1001/archsurg.1989.01410110044009. [DOI] [PubMed] [Google Scholar]
  122. Pohlmann R., Nagel G., Hille A., Wendland M., Waheed A., Braulke T., von Figura K. Mannose 6-phosphate specific receptors: structure and function. Biochem Soc Trans. 1989 Feb;17(1):15–16. doi: 10.1042/bst0170015. [DOI] [PubMed] [Google Scholar]
  123. Poulain D., Hopwood V., Vernes A. Antigenic variability of Candida albicans. Crit Rev Microbiol. 1985;12(3):223–270. doi: 10.3109/10408418509104430. [DOI] [PubMed] [Google Scholar]
  124. Poulain D., Tronchin G., Vernes A., Popeye R., Biguet J. Antigenic variations of Candida albicans in vivo and in vitro--relationships between P antigens and serotypes. Sabouraudia. 1983 Jun;21(2):99–112. [PubMed] [Google Scholar]
  125. Raschke W. C., Kern K. A., Antalis C., Ballou C. E. Genetic control of yeast mannan structure. Isolation and characterization of mannan mutants. J Biol Chem. 1973 Jul 10;248(13):4660–4666. [PubMed] [Google Scholar]
  126. Reiss E., Kuykendall R. J., Kaufman L. Antigenemia in rabbits infected with Candida albicans serotype B: detection by enzyme immunoassay and preliminary characterization of the antigen. J Med Vet Mycol. 1986 Aug;24(4):259–269. [PubMed] [Google Scholar]
  127. Reiss E., Patterson D. G., Yert L. W., Holler J. S., Ibrahim B. K. Structural analysis of mannans from Candida albicans serotypes A and B and from Torulopsis glabrata by methylation gas chromatography mass spectrometry and exo-alpha-mannanase. Biomed Mass Spectrom. 1981 Jun;8(6):252–255. doi: 10.1002/bms.1200080605. [DOI] [PubMed] [Google Scholar]
  128. Reiss E., Stone S. H., Hasenclever H. F. Serological and cellular immune activity of peptidoglucomannan fractions of Candida albicans cell walls. Infect Immun. 1974 May;9(5):881–890. doi: 10.1128/iai.9.5.881-890.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  129. Rocklin R. E., Chilgren R. A., Hong R., David J. R. Transfer of cellular hypersensitivity in chronic mucocutaneous candidiasis monitored in vivo and in vitro. Cell Immunol. 1970 Sep;1(3):290–299. doi: 10.1016/0008-8749(70)90050-x. [DOI] [PubMed] [Google Scholar]
  130. Rocklin R. E. Production of migration inhibitory factor by non-dividing lymphocytes. J Immunol. 1973 Mar;110(3):674–678. [PubMed] [Google Scholar]
  131. Rogers T. J., Balish E. Immunity to Candida albicans. Microbiol Rev. 1980 Dec;44(4):660–682. doi: 10.1128/mr.44.4.660-682.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  132. Rosenthal A. S., Shevach E. M. Function of macrophages in antigen recognition by guinea pig T lymphocytes. I. Requirement for histocompatible macrophages and lymphocytes. J Exp Med. 1973 Nov 1;138(5):1194–1212. doi: 10.1084/jem.138.5.1194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  133. SALVIN S. B. Immunologic aspects of the mycoses. Prog Allergy. 1963;7:213–331. doi: 10.1159/000391342. [DOI] [PubMed] [Google Scholar]
  134. Saxena A., Hammer C. F., Cihlar R. L. Analysis of mannans of two relatively avirulent mutant strains of Candida albicans. Infect Immun. 1989 Feb;57(2):413–419. doi: 10.1128/iai.57.2.413-419.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  135. Saxena A., McElhaney-Feser G. E., Cihlar R. L. Mannan composition of the hyphal form of two relatively avirulent mutants of Candida albicans. Infect Immun. 1990 Jul;58(7):2061–2066. doi: 10.1128/iai.58.7.2061-2066.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  136. Scaringi L., Marconi P., Boccanera M., Tissi L., Bistoni F., Cassone A. Cell wall components of Candida albicans as immunomodulators: induction of natural killer and macrophage-mediated peritoneal cell cytotoxicity in mice by mannoprotein and glucan fractions. J Gen Microbiol. 1988 May;134(5):1265–1274. doi: 10.1099/00221287-134-5-1265. [DOI] [PubMed] [Google Scholar]
  137. Schwartz R. H. A cell culture model for T lymphocyte clonal anergy. Science. 1990 Jun 15;248(4961):1349–1356. doi: 10.1126/science.2113314. [DOI] [PubMed] [Google Scholar]
  138. Shepherd M. G. Cell envelope of Candida albicans. Crit Rev Microbiol. 1987;15(1):7–25. doi: 10.3109/10408418709104445. [DOI] [PubMed] [Google Scholar]
  139. Shepherd M. G., Poulter R. T., Sullivan P. A. Candida albicans: biology, genetics, and pathogenicity. Annu Rev Microbiol. 1985;39:579–614. doi: 10.1146/annurev.mi.39.100185.003051. [DOI] [PubMed] [Google Scholar]
  140. Shepherd V. L., Campbell E. J., Senior R. M., Stahl P. D. Characterization of the mannose/fucose receptor on human mononuclear phagocytes. J Reticuloendothel Soc. 1982 Dec;32(6):423–431. [PubMed] [Google Scholar]
  141. Shepherd V. L., Lee Y. C., Schlesinger P. H., Stahl P. D. L-Fucose-terminated glycoconjugates are recognized by pinocytosis receptors on macrophages. Proc Natl Acad Sci U S A. 1981 Feb;78(2):1019–1022. doi: 10.1073/pnas.78.2.1019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  142. Sherblom A. P., Decker J. M., Muchmore A. V. The lectin-like interaction between recombinant tumor necrosis factor and uromodulin. J Biol Chem. 1988 Apr 15;263(11):5418–5424. [PubMed] [Google Scholar]
  143. Sherblom A. P., Sathyamoorthy N., Decker J. M., Muchmore A. V. IL-2, a lectin with specificity for high mannose glycopeptides. J Immunol. 1989 Aug 1;143(3):939–944. [PubMed] [Google Scholar]
  144. Shibata N., Fukasawa S., Kobayashi H., Tojo M., Yonezu T., Ambo A., Ohkubo Y., Suzuki S. Structural analysis of phospho-D-mannan-protein complexes isolated from yeast and mold form cells of Candida albicans NIH A-207 serotype A strain. Carbohydr Res. 1989 Apr 15;187(2):239–253. doi: 10.1016/0008-6215(89)80006-0. [DOI] [PubMed] [Google Scholar]
  145. Shibata N., Ichikawa T., Tojo M., Takahashi M., Ito N., Okubo Y., Suzuki S. Immunochemical study on the mannans of Candida albicans NIH A-207, NIH B-792, and J-1012 strains prepared by fractional precipitation with cetyltrimethylammonium bromide. Arch Biochem Biophys. 1985 Dec;243(2):338–348. doi: 10.1016/0003-9861(85)90511-9. [DOI] [PubMed] [Google Scholar]
  146. Shibata N., Kobayashi H., Tojo M., Suzuki S. Characterization of phosphomannan-protein complexes isolated from viable cells of yeast and mycelial forms of Candida albicans NIH B-792 strain by the action of Zymolyase-100T. Arch Biochem Biophys. 1986 Dec;251(2):697–708. doi: 10.1016/0003-9861(86)90379-6. [DOI] [PubMed] [Google Scholar]
  147. Skerl K. G., Calderone R. A., Segal E., Sreevalsan T., Scheld W. M. In vitro binding of Candida albicans yeast cells to human fibronectin. Can J Microbiol. 1984 Feb;30(2):221–227. doi: 10.1139/m84-033. [DOI] [PubMed] [Google Scholar]
  148. Slutsky B., Buffo J., Soll D. R. High-frequency switching of colony morphology in Candida albicans. Science. 1985 Nov 8;230(4726):666–669. doi: 10.1126/science.3901258. [DOI] [PubMed] [Google Scholar]
  149. Sly W. S., Fischer H. D. The phosphomannosyl recognition system for intracellular and intercellular transport of lysosomal enzymes. J Cell Biochem. 1982;18(1):67–85. doi: 10.1002/jcb.1982.240180107. [DOI] [PubMed] [Google Scholar]
  150. Sohnle P. G., Kirkpatrick C. H. Epidermal proliferation in the defense against experimental cutaneous candidiasis. J Invest Dermatol. 1978 Mar;70(3):130–133. doi: 10.1111/1523-1747.ep12258536. [DOI] [PubMed] [Google Scholar]
  151. Soll D. R. High-frequency switching in Candida albicans and its relations to vaginal candidiasis. Am J Obstet Gynecol. 1988 Apr;158(4):997–1001. doi: 10.1016/0002-9378(88)90113-5. [DOI] [PubMed] [Google Scholar]
  152. Springer T. A., Dustin M. L., Kishimoto T. K., Marlin S. D. The lymphocyte function-associated LFA-1, CD2, and LFA-3 molecules: cell adhesion receptors of the immune system. Annu Rev Immunol. 1987;5:223–252. doi: 10.1146/annurev.iy.05.040187.001255. [DOI] [PubMed] [Google Scholar]
  153. Stephenson J. D., Shepherd V. L. Purification of the human alveolar macrophage mannose receptor. Biochem Biophys Res Commun. 1987 Oct 29;148(2):883–889. doi: 10.1016/0006-291x(87)90958-2. [DOI] [PubMed] [Google Scholar]
  154. Stoolman L. M. Adhesion molecules controlling lymphocyte migration. Cell. 1989 Mar 24;56(6):907–910. doi: 10.1016/0092-8674(89)90620-x. [DOI] [PubMed] [Google Scholar]
  155. Sullivan P. A., Yin C. Y., Molloy C., Templeton M. D., Shepherd M. G. An analysis of the metabolism and cell wall composition of Candida albicans during germ-tube formation. Can J Microbiol. 1983 Nov;29(11):1514–1525. doi: 10.1139/m83-233. [DOI] [PubMed] [Google Scholar]
  156. Sundsmo J. S., Götze O. Human monocyte spreading induced by activated factor B of the complement alternative pathway: differential effects of Fab' and F(ab')2 antibody fragments directed to C5, C6, and C7. Cell Immunol. 1983 Apr 1;77(1):176–186. doi: 10.1016/0008-8749(83)90017-5. [DOI] [PubMed] [Google Scholar]
  157. Sung S. S., Nelson R. S., Silverstein S. C. Yeast mannans inhibit binding and phagocytosis of zymosan by mouse peritoneal macrophages. J Cell Biol. 1983 Jan;96(1):160–166. doi: 10.1083/jcb.96.1.160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  158. Suzuki M., Fukazawa Y. Immunochemical characterization of Candida albicans cell wall antigens: specific determinant of Candida albicans serotype A mannan. Microbiol Immunol. 1982;26(5):387–402. doi: 10.1111/j.1348-0421.1982.tb00189.x. [DOI] [PubMed] [Google Scholar]
  159. TAMM I., HORSFALL F. L., Jr A mucoprotein derived from human urine which reacts with influenza, mumps, and Newcastle disease viruses. J Exp Med. 1952 Jan;95(1):71–97. doi: 10.1084/jem.95.1.71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  160. Tarentino A. L., Gómez C. M., Plummer T. H., Jr Deglycosylation of asparagine-linked glycans by peptide:N-glycosidase F. Biochemistry. 1985 Aug 13;24(17):4665–4671. doi: 10.1021/bi00338a028. [DOI] [PubMed] [Google Scholar]
  161. Tarleton R. L. Trypanosoma cruzi-induced suppression of IL-2 production. II. Evidence for a role for suppressor cells. J Immunol. 1988 Apr 15;140(8):2769–2773. [PubMed] [Google Scholar]
  162. Thurman G. B., Braude I. A., Gray P. W., Oldham R. K., Stevenson H. C. MIF-like activity of natural and recombinant human interferon-gamma and their neutralization by monoclonal antibody. J Immunol. 1985 Jan;134(1):305–309. [PubMed] [Google Scholar]
  163. Tojo M., Shibata N., Kobayashi M., Mikami T., Suzuki M., Suzuki S. Preparation of monoclonal antibodies reactive with beta-1,2-linked oligomannosyl residues in the phosphomannan-protein complex of Candida albicans NIH B-792 strain. Clin Chem. 1988 Mar;34(3):539–543. [PubMed] [Google Scholar]
  164. Tollemar J., Ringdén O., Holmberg K. Candida albicans: mannan and protein activation of cells from various human lymphoid organs. Scand J Immunol. 1989 Oct;30(4):473–480. doi: 10.1111/j.1365-3083.1989.tb02452.x. [DOI] [PubMed] [Google Scholar]
  165. Tomai M. A., Elmquist B. J., Warmka S. M., Fitzgerald T. J. Macrophage-mediated suppression of con A-induced IL-2 production in spleen cells from syphilitic rabbits. J Immunol. 1989 Jul 1;143(1):309–314. [PubMed] [Google Scholar]
  166. Tsuchiya T., Fukazawa Y., Taguchi M., Nakase T., Shinoda T. Serologic aspects on yeast classification. Mycopathol Mycol Appl. 1974 Aug 30;53(1):77–91. doi: 10.1007/BF02127199. [DOI] [PubMed] [Google Scholar]
  167. Twomey J. J., Waddell C. C., Krantz S., O'reilly R., L'esperance P., Good R. A. Chronic mucocutaneous candidiasis with macrophage dysfunction, a plasma inhibitor, and co-existent aplastic anemia. J Lab Clin Med. 1975 Jun;85(6):968–977. [PubMed] [Google Scholar]
  168. Unanue E. R. Antigen-presenting function of the macrophage. Annu Rev Immunol. 1984;2:395–428. doi: 10.1146/annurev.iy.02.040184.002143. [DOI] [PubMed] [Google Scholar]
  169. Valdimarsson H., Higgs J. M., Wells R. S., Yamamura M., Hobbs J. R., Holt P. J. Immune abnormalities associated with chronic mucocutaneous candidiasis. Cell Immunol. 1973 Mar;6(3):348–361. doi: 10.1016/0008-8749(73)90035-x. [DOI] [PubMed] [Google Scholar]
  170. Valdimarsson H., Holt L., Riches H. R., Hobbs J. R. Lymphocyte abnormality in chronic mucocutaneous candidiasis. Lancet. 1970 Jun 13;1(7659):1259–1261. doi: 10.1016/s0140-6736(70)91742-3. [DOI] [PubMed] [Google Scholar]
  171. Valentini A. F., Merli A., Guerra L., Piana G. Rapporto candida-ospite: fisiologia e patologia. Minerva Stomatol. 1989 Feb;38(2):243–260. [PubMed] [Google Scholar]
  172. Venezia R. A., Lachapelle R. C. The use of ferritin-conjugated antibodies in the study of cell wall components of Candida albicans. Can J Microbiol. 1973 Nov;19(11):1445–1448. doi: 10.1139/m73-232. [DOI] [PubMed] [Google Scholar]
  173. Wahl S. M., Wong H., McCartney-Francis N. Role of growth factors in inflammation and repair. J Cell Biochem. 1989 Jun;40(2):193–199. doi: 10.1002/jcb.240400208. [DOI] [PubMed] [Google Scholar]
  174. Wang M., Friedman H., Djeu J. Y. Enhancement of human monocyte function against Candida albicans by the colony-stimulating factors (CSF): IL-3, granulocyte-macrophage-CSF, and macrophage-CSF. J Immunol. 1989 Jul 15;143(2):671–677. [PubMed] [Google Scholar]
  175. Weaver C. T., Unanue E. R. The costimulatory function of antigen-presenting cells. Immunol Today. 1990 Feb;11(2):49–55. doi: 10.1016/0167-5699(90)90018-5. [DOI] [PubMed] [Google Scholar]
  176. Webb D. R., Nowowiejski I. Mitogen-induced changes in lymphocyte prostaglandin levels: a signal for the induction of suppressor cell activity. Cell Immunol. 1978 Nov;41(1):72–85. doi: 10.1016/s0008-8749(78)80029-x. [DOI] [PubMed] [Google Scholar]
  177. Weiser W. Y., Remold H. G., Block L. H., David J. R. Dissociation of human interferon-gamma-like activity from migration-inhibition factor. Cell Immunol. 1984 Oct 1;88(1):109–122. doi: 10.1016/0008-8749(84)90056-x. [DOI] [PubMed] [Google Scholar]
  178. Weiser W. Y., Temple P. A., Witek-Giannotti J. S., Remold H. G., Clark S. C., David J. R. Molecular cloning of a cDNA encoding a human macrophage migration inhibitory factor. Proc Natl Acad Sci U S A. 1989 Oct;86(19):7522–7526. doi: 10.1073/pnas.86.19.7522. [DOI] [PMC free article] [PubMed] [Google Scholar]
  179. Wells R. S. Chronic mucocutaneous candidiasis: a clinical classification. Proc R Soc Med. 1973 Aug;66(8):801–802. [PMC free article] [PubMed] [Google Scholar]
  180. Wells R. S., Higgs J. M., Macdonald A., Valdimarsson H., Holt P. J. Familial chronic muco-cutaneous candidiasis. J Med Genet. 1972 Sep;9(3):302–310. doi: 10.1136/jmg.9.3.302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  181. Witkin S. S., Hirsch J., Ledger W. J. A macrophage defect in women with recurrent Candida vaginitis and its reversal in vitro by prostaglandin inhibitors. Am J Obstet Gynecol. 1986 Oct;155(4):790–795. doi: 10.1016/s0002-9378(86)80022-9. [DOI] [PubMed] [Google Scholar]
  182. Witkin S. S., Yu I. R., Ledger W. J. Inhibition of Candida albicans--induced lymphocyte proliferation by lymphocytes and sera from women with recurrent vaginitis. Am J Obstet Gynecol. 1983 Dec 1;147(7):809–811. doi: 10.1016/0002-9378(83)90044-3. [DOI] [PubMed] [Google Scholar]
  183. Yednock T. A., Rosen S. D. Lymphocyte homing. Adv Immunol. 1989;44:313–378. doi: 10.1016/s0065-2776(08)60645-8. [DOI] [PubMed] [Google Scholar]
  184. Zanders E. D., Feldmann M., Green N., Lamb J. R. Direct evaluation of antigen binding to human T lymphocyte clones: involvement of major histocompatibility complex products in antigen binding. Eur J Immunol. 1984 Dec;14(12):1101–1105. doi: 10.1002/eji.1830141207. [DOI] [PubMed] [Google Scholar]

Articles from Clinical Microbiology Reviews are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES